Retatrutide: Dosage, Protocol, and Research Guide
Triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors
Mechanism
Novel tri-agonist activating GLP-1, GIP, and glucagon receptors. The glucagon component adds enhanced energy expenditure and lipolysis to the glucose control and appetite suppression from GLP-1/GIP.
Protocol at a glance
| Starting dose | 1mg |
|---|---|
| Maintenance dose | 8-12mg |
| Maximum dose | 12mg |
| Frequency | Once weekly |
| Typical duration | Ongoing therapy |
| Route | Subcutaneous |
| Injection site | Abdomen, thigh, or upper arm |
| Timing | Any time of day |
Titration schedule
| Week | Dose | Notes |
|---|---|---|
| 1 | 1mg | Initial dose for 4 weeks |
| 5 | 4mg | First increase |
| 9 | 8mg | Standard maintenance |
| 13 | 12mg | Maximum dose |
Side effects
- Nausea
- Vomiting
- Diarrhea
- Decreased appetite
- Injection site reactions
Contraindications
- Type 1 diabetes
- History of pancreatitis
Protocol notes
- Newest triple agonist peptide in development
- More potent than dual agonists for weight loss
- Currently in Phase 3 clinical trials
- May achieve 20-25% weight loss in clinical studies
Frequently asked questions
Is Retatrutide legal?
Retatrutide is currently in Phase 3 clinical trials and is not FDA-approved for human use. Its legal status depends on jurisdiction and intended use. Regulatory approval pathways remain ongoing. Any consideration of Retatrutide should be made in consultation with a licensed physician and in compliance with local regulations regarding research peptides.
What is the standard dosing protocol for Retatrutide?
Retatrutide is administered once weekly via subcutaneous injection. The starting dose is 1mg per week, with a maintenance dose range of 8-12mg per week, capped at a maximum of 12mg weekly. Injections can be administered to the abdomen, thigh, or upper arm at any time of day. Dose adjustments should be made under medical guidance based on individual tolerance and response.
What are the main side effects of Retatrutide?
The most commonly reported side effects of Retatrutide include nausea, vomiting, diarrhea, decreased appetite, and injection site reactions. These effects are typically transient and often diminish as the body adjusts to the peptide over the initial treatment period. Importantly, Retatrutide is contraindicated for individuals with Type 1 diabetes or a history of pancreatitis.
Can Retatrutide be cycled?
Research on cycling protocols for Retatrutide remains limited. Available data indicates Retatrutide is intended for ongoing therapy rather than cycled dosing. Any decisions about cycling should be made with a qualified healthcare provider who can assess individual response and determine the appropriate treatment protocol for your specific situation.
Can you stack Retatrutide with other peptides?
Research on stacking protocols involving Retatrutide with other peptides remains limited. Given that Retatrutide already activates three hormone receptor pathways (GLP-1, GIP, and glucagon receptors), any combination with other peptides should only be considered under direct medical supervision with careful monitoring. Do not attempt stacking without professional guidance.
What lab markers should be monitored while using Retatrutide?
Research on specific lab monitoring protocols for Retatrutide remains limited. Given its mechanism of action on glucose and energy metabolism, relevant monitoring would likely include fasting glucose, HbA1c, lipid panels, and liver function tests. Individual monitoring protocols should be established with a qualified healthcare provider based on baseline health status and risk factors.
What does Retatrutide feel like when you are using it?
Individual experiences with Retatrutide vary. The primary intended effect is decreased appetite, which supports the weight management mechanism. Some users report nausea, vomiting, or diarrhea, particularly early in treatment, while others may experience injection site reactions. Most side effects tend to diminish as the body adjusts. The subjective experience depends on starting dose, individual metabolism, and individual tolerance to activation of the GLP-1, GIP, and glucagon pathways.
More GLP-1 & Weight Loss peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.